Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
about
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's diseaseElectroconvulsive therapy in Parkinson's diseaseEltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.STN-DBS Reduces Saccadic Hypometria but Not Visuospatial Bias in Parkinson's Disease Patients.Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's DiseaseFacial Emotion Recognition and Expression in Parkinson's Disease: An Emotional Mirror Mechanism?Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugsUsefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyRole of basal ganglia circuits in resisting interference by distracters: a swLORETA studySelegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease.Neuropsychiatric characteristics of GBA-associated Parkinson disease.Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.Dysrhythmia of timed movements in Parkinson's disease and freezing of gaitShort- and long-term effects of tactile massage on salivary cortisol concentrations in Parkinson's disease: a randomised controlled pilot study.Gait improvement via rhythmic stimulation in Parkinson's disease is linked to rhythmic skillsPredictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation.Trust behavior in Parkinson's disease: results of a trust game experiment.Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.Assessment of brainstem function with auricular branch of vagus nerve stimulation in Parkinson's disease.Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's diseaseEffect of dopamine therapy on nonverbal affect burst recognition in Parkinson's disease.Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.Impairment of vowel articulation as a possible marker of disease progression in Parkinson's disease.Exenatide and the treatment of patients with Parkinson's diseaseImpairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndromeSubthalamic nucleus deep brain stimulation in early stage Parkinson's disease.Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.Monitoring of 30 marker candidates in early Parkinson disease as progression markers.Enteric neurons from Parkinson's disease patients display ex vivo aberrations in mitochondrial structure.Default mode network differences between rigidity- and tremor-predominant Parkinson's diseaseTracking Parkinson's: Study Design and Baseline Patient Data.Case control polysomnographic studies of sleep disorders in Parkinson's disease.Free-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor.Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Correlation of Quantitative Motor State Assessment Using a Kinetograph and Patient Diaries in Advanced PD: Data from an Observational Study.
P2860
Q24597126-AA282A2A-57A9-4A10-B8E0-EC191B580BE7Q26786623-E4061F73-188A-43AF-8FFC-FC1D6BDC76A5Q27303857-CADAB491-A126-4A06-8B60-9E304E63BA8AQ27320937-7D33A802-E17E-4FE9-AB90-FF93CFC74D4FQ27327538-932B9DC1-6887-4D4A-B8D6-967424BFC65AQ28469512-666C161C-3401-492A-9D27-EC0B9EAD1DDAQ28534024-31FFEA72-5FDD-4EC4-863C-02554E4FD66BQ28553194-AACF77A3-ECC5-478B-9707-9D23AE9C821CQ28727519-57BB822D-C597-48FF-BF4E-499FE20461DAQ28730890-A0BC0F5F-F456-482D-BDE5-3CB43538CBC5Q29994860-13835640-E734-4917-AAFF-88ED83F5DA82Q30275630-47DB687C-005A-4290-B838-900512FDCAEDQ30276836-4BC87B72-A5DD-4521-A430-636ECC8D3538Q30278909-0EE367B5-65C6-4B58-9D6B-F9AA132758C8Q30356704-9906E355-7D71-4C07-8367-890D1D91E6DFQ30362481-4CF75E26-B31B-4AF6-970D-3B0F14D4C1E0Q30398503-046CFDF4-2B44-458F-A4F4-F1904D9CAFEDQ30400127-F8CF24B8-0697-431B-B369-D7D3F800555EQ30405612-19953D9D-A767-4589-98AD-0E19F5AC7199Q30405991-3F9909D5-5CAD-4EDB-8799-06C2EDCA0E1CQ30407589-4E803F22-D2F0-4A93-B5AF-35D197E344AFQ30409132-5730DBC2-B432-49A9-8682-7DC4658E00BAQ30413998-F3C85EF0-6A67-4212-ACC9-A6BBEF7D375BQ30417007-53BD05F8-3037-46B6-8E47-5CE62780CC15Q30426047-8341A24C-2FCF-47E5-B1E3-75AB609C2151Q30441215-44D6D7B8-AB61-4A87-9BB3-B379A728A544Q30461883-65592BF7-76CA-47CA-9818-F34805041C33Q30469875-2A0B9364-DE81-4EBD-A8D4-4541531F94FBQ30540208-DCE879E5-07E9-4B48-A21A-6E90F3072BF3Q30544858-89CE4AF9-30D3-4E0E-9356-2205AFFEF55FQ30584275-B7F6EFF3-6FFF-486A-8C11-0B687AFF37F2Q30585564-C15219F2-26C5-4FF1-AC64-6E3ACEEEB5D4Q30783504-23DF5C14-EBB8-4A53-A1AF-AC7E99F8E745Q30810965-3A6B186D-0885-40ED-8343-39C9F9875E17Q30843485-A11F03FB-FCF3-4BCA-ADEE-9F94808E51DBQ31008758-9047A34C-B399-4C31-A962-8A3B59678D41Q31028156-10DEA801-AB70-4F93-9812-9C3E15E0051EQ31080092-99D4851A-A12A-4B4E-B4CF-ADD6FF1CF14FQ31097087-D554C5E6-91DD-4D35-8BE9-A5CED7D54856Q31123361-2E0E5313-0B92-44E4-9DCC-F3DC7A44AA64
P2860
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
@en
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
@nl
type
label
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
@en
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
@nl
prefLabel
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
@en
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
@nl
P2093
P50
P356
P1433
P1476
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
@en
P2093
Caroline Rick
Claire L Tomlinson
Smitaa Patel
P304
P356
10.1002/MDS.23429
P407
P577
2010-11-01T00:00:00Z